Jounce Therapeutics Inc [JNCE] Rallies after Gilead Deal – What Next?
Nicholas K
September 1, 2020
Jounce Therapeutics Inc [NASDAQ:JNCE] is a top performer this afternoon. After trading in a range all through August, the stock has gapped up and is